Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Apr 2011 15:44

RNS Number : 2659E
F&C Private Equity Trust PLC
04 April 2011
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

 

For filings with the FSA include the annex

For filings with issuer exclude the annex

 

TR-1: Notifications of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

F&C Private Equity Trust Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to notification obligation:

 

Martin Currie Investment Management Limited

 

 

4. Full name of shareholder(s) (if different from 3):

 

Martin Currie Portfolio Investment Trust plc

 

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

1 April 2011

 

6. Date on which issuer notified:

 

4 April 2011

 

 

7. Threshold(s) that is/are crossed or reached:

Ordinary shares - from 10.8% to 3.9%

RVS shares - from 46.4% to 0%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

 

Direct

 

Indirect

 

Direct

 

Indirect

GB0030738271 7,836,624 7,836,624 2,836,624 2,836,624 3.9%

GB0030738164 31,097,772 31,097,772 0 0 0.0%

 

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

2,836,624

3.9%

 

 

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

 

 

 

Proxy Voting:

 

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

 

13. Additional information:

 

14 Contact name:

 

Steven Ross

15. Contact telephone name:

 

020 7628 8000

 

For notes on how to complete form TR-1 please see the FSA website.

 

 

 

 

 

  

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSSSRAUASRAR
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.